US-based biopharmaceutical company NexBio, Inc. has been awarded a $US6 million phase II Small Business Innovation Research (SBIR) grant by the US NIAID

Author:  

Publisher: Adis International

ISSN: 1173-5503

Source: PharmacoEconomics and Outcomes News, Vol.1, Iss.485, 2005-01, pp. : 15-15

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract